The Evaluation Of Adding Erythropoietin In Cardioplegic Solution On The Time Required for Mechanical Ventilation and The Need for Inotrop In Pattions After CABG In Rasool-e-Akram Hospital
Phase 3
Recruiting
- Conditions
- Coronary ischemic patients.Chronic ischemic heart disease
- Registration Number
- IRCT20191216045755N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with ischemic coronary artery disease who are not eligible for angiographic treatment and who are candidates for surgery for coronary artery disease (CABG) 2-Patients with ischemic coronary artery disease aged 40 to 80 years
Exclusion Criteria
1- Patients undergoing heart replacement surgery under open heart surgery 2- Anatomical heart disease undergoing open heart surgery 3- Patients with coronary artery disease who have cardiac-respiratory arrest under open heart surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence or absence of erythropoietin in the cardioplegia solution. Timepoint: After surgery. Method of measurement: Researcher Information.
- Secondary Outcome Measures
Name Time Method Total postoperative hospital stay. Timepoint: After Surgery. Method of measurement: Based on the case.;Duration of ICU admission. Timepoint: Operation time until leaving ICU. Method of measurement: Based on the case.;The dose of inotropes required after surgery. Timepoint: After Surgery. Method of measurement: Based on the case.